BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21736184)

  • 1. Independently owned pharmacy closures in rural America, 2003-2010.
    Boyle K; Ullrich F; Mueller K
    Rural Policy Brief; 2011 Jun; (2011 5):1-4. PubMed ID: 21736184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independently owned pharmacy closures in rural America.
    Boyle K; Ullrich F; Mueller K
    Rural Policy Brief; 2012 Jul; (2012 4):1-4. PubMed ID: 22830100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update: independently owned pharmacy closures in rural America, 2003-2013.
    Ullrich F; Mueller KJ; ;
    Rural Policy Brief; 2014 Jun; (2014 7):1-4. PubMed ID: 25399472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rural pharmacy closures: implications for rural communities.
    Todd K; Ullrich F; Mueller K;
    Rural Policy Brief; 2013 Jan; (2012 5):1-5. PubMed ID: 25399456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independently owned pharmacy closures in rural America.
    Klepser D; Xu L; Ullrich F; Mueller K
    Rural Policy Brief; 2008 Jul; (2008 2):1-4. PubMed ID: 19688903
    [No Abstract]   [Full Text] [Related]  

  • 6. Update: Independently Owned Pharmacy Closures in Rural America, 2003-2018.
    Salako A; Ullrich F; Mueller KJ
    Rural Policy Brief; 2018 Jul; 2018(2):1-6. PubMed ID: 30080364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes and consequences of rural pharmacy closures: a multi-case study.
    Todd K; Westfall K; Doucette B; Ullrich F; Mueller K; ;
    Rural Policy Brief; 2013 Aug; (2013 11):1-4. PubMed ID: 25399462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliance on independently owned pharmacies in rural America.
    Shambaugh-Miller MD; Vanosdel N; Mueller KJ
    Rural Policy Brief; 2007 Nov; (PB2007-6):1-4. PubMed ID: 18828246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy services in rural areas: is the problem geographic access or financial access?
    Casey MM; Klingner J; Moscovice I
    J Rural Health; 2002; 18(3):467-77. PubMed ID: 12186321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future economic outlook of Nebraska rural community pharmacies based on break-even analysis of community operational costs and county population.
    Keast SL; Jacobs E; Harrison D; Farmer K; Thompson D
    Res Social Adm Pharm; 2010 Sep; 6(3):209-20. PubMed ID: 20813334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic and economic characteristics associated with sole county pharmacy closures, 2006-2010.
    Weigel P; Ullrich F; Mueller K; ;
    Rural Policy Brief; 2013 Nov; (2013 15):1-4. PubMed ID: 25399463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Rural Communities with a Sole, Independently Owned Pharmacy.
    Nattinger M; Ullrich F; Mueller KJ; ;
    Rural Policy Brief; 2015 Apr; (2015 6):1-4. PubMed ID: 26793812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in community pharmacy counts and closures before and after the implementation of Medicare part D.
    Klepser DG; Xu L; Ullrich F; Mueller KJ
    J Rural Health; 2011; 27(2):168-75. PubMed ID: 21457309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How might the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 affect the financial viability of rural pharmacies? An analysis of preimplementation prescription volume and payment sources in rural and urban areas.
    Fraher EP; Slifkin RT; Smith L; Randolph R; Rudolf M; Holmes GM
    J Rural Health; 2005; 21(2):114-21. PubMed ID: 15859048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the impacts of the Medicare Modernization Act: concerns of congressional staff.
    Mueller KJ; Coburn AF; MacKinney AC; McBride TD; Slifkin RT; Wakefield MK
    J Rural Health; 2005; 21(3):194-7. PubMed ID: 16092291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.